Tag: well

From Pearl Studio, the Studio Behind Kung Fu Panda 3, the Mythological Comedy Marks the Next Major Chinese Animated Release as Chinese Animation Continues...

HEFEI, China, June 10, 2026 /PRNewswire/ -- Sungrow recently announced that its SG510HX utility string inverter (SG465HX for the Middle East region, offering equivalent...

CALGARY, AB, June 10, 2026 /PRNewswire/ - Horizon Petroleum Ltd. ("Horizon" or the "Company") (TSXV: HPL) (FRA: HPM) (Tradegate: HPM) is pleased to announce the...

Appointment expands consumer choice and convenience to American Standard products and solutions to Australians nationwide for both retail and commercial marketsMELBOURNE, Australia, June 11, 2026...

LOS ANGELES, June 10, 2026 /PRNewswire/ -- Prostate pleasure may be one of the few forms of pleasure men can uniquely experience. But why...

CALGARY AB, June 10, 2026 /CNW/ - InPlay Oil Corp. (TSX: IPO) (OTCQX: IPOOF) ("InPlay" or the "Company") announced today the voting results for the election of directors at its...

New collaboration brings Visa's global payment network to one of the largest AI platforms and aims to support seamless, secure transactions and broader AI-powered...

DURHAM, N.C., June 10, 2026 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a commercial-stage biotechnology platform company developing universally implantable, bioengineered human tissues at commercial scale, today announced the pricing of an underwritten public offering of 47,619,048 shares of its common stock at a public offering price of $1.05 per share. The aggregate gross proceeds from this offering are expected to be $50 million, before deducting underwriting discounts and commissions and other offering expenses payable by Humacyte. The closing of the offering is expected to occur on or about June 12, 2026, subject to the satisfaction of customary closing conditions. In addition, Humacyte has granted the underwriters an option for a period of 30 days to purchase up to an additional 7,142,857 shares of Humacyte’s common stock at the public offering price, less underwriting discounts and commissions. All of the shares of common stock are being sold by Humacyte.

Mrs Mak and McDull Visit 24 Malls and Markets, Launching Exclusive Themed Premiums and Dining OffersThe "Hundred Flavours Survey" drew over 6,000 participants, uncovering...

Defiance ETFs to Launch SPCU, The 2X SpaceX ETF, as the SpaceX (SPCX) IPO Nears

Scholarship aims to support students of color pursuing careers in dentistry to improve access to representative oral care across the state. SEATTLE, June 10,...

Establishes a regulatory-compliant, state-of-the-art Genome-Edited (GE) Crop Field Testing Facility to accelerate global commercialization.Enables comprehensive field evaluation of a diversified crop portfolio, including drought...

SYDNEY, June 11, 2026 /PRNewswire/ -- Insta360 announced Luna Ultra, its flagship gimbal camera co-engineered with Leica, built to combine professional imaging, 3-axis stabilization, and...